Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiviral therapy: current options and challenges.

P Reusser1

  • 1Department of Medicine, University Hospital, Basel. pierre.reusser@jura.ch

Schweizerische Medizinische Wochenschrift
|April 26, 2000
PubMed
Summary

Antiviral drugs effectively manage viral infections like herpes and hepatitis. Newer oral medications offer improved convenience, but drug resistance in herpes viruses requires further research into alternative treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia.

Bone marrow transplantation·2008
Same author

Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT.

Bone marrow transplantation·2008
Same author

Swiss recommendations for the management of varicella zoster virus infections.

Swiss medical weekly·2007
Same author

Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time.

Bone marrow transplantation·2005
Same author

Management of CMV infections: recommendations from the infectious diseases working party of the EBMT.

Bone marrow transplantation·2004
Same author

Oral valganciclovir: a new option for treatment of cytomegalovirus infection and disease in immunocompromised hosts.

Expert opinion on investigational drugs·2002

Area of Science:

  • Virology
  • Pharmacology
  • Infectious Diseases

Background:

  • Viral infections pose significant global health challenges.
  • Antiviral drug development and diagnostics have advanced treatment strategies.
  • Management of herpes simplex virus, varicella-zoster virus, cytomegalovirus, influenza, and hepatitis B and C are key areas.

Purpose of the Study:

  • To review current drug treatment options for viral infections (excluding HIV).
  • To discuss advances in antiviral drug development and diagnostics.
  • To highlight emerging challenges like antiviral resistance.

Main Methods:

  • Literature review of current antiviral therapies and diagnostic methods.
  • Analysis of clinical trial data for newer antiviral agents.
  • Discussion of drug resistance mechanisms and potential solutions.

Main Results:

  • Newer oral antivirals (valaciclovir, famciclovir) offer improved bioavailability and convenience.
  • Oral lamivudine is an alternative for chronic hepatitis B.
  • Combination therapy (ribavirin with interferon-alpha) is superior for chronic hepatitis C.
  • Neuraminidase inhibitors (zanamivir, oseltamivir) are effective against influenza A and B.
  • Emerging herpes virus resistance to antivirals is a concern.

Conclusions:

  • Efficient management strategies exist for several viral infections.
  • Oral antiviral agents enhance patient compliance and reduce the need for intravenous therapy.
  • Antiviral drug resistance necessitates the development of alternative treatments and further research.

Related Experiment Videos